Balaxi Pharmaceuticals
BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth
1d
0.2%
1w
3.6%
1m
5.7%
3m
8.4%
6m
0.6%
1y
49.7%
5y
27.4%
10y
19.3%
all
22.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 24.4 0.2%
22.5
29.9
Company Overview

Sales
270 Cr
Growth: -2.0%
Profit after Tax
1.42 Cr
Growth: -85.0%
Micro Cap
135 Cr
P/E: 94.0x
Industry P/E: 27.3x
Fundamentals

Sales (Cr) ₹ 270
Growth -2.0%
EBITDA 3.2%
P/S 0.5x
Dividend 0.0%
P/E 94.0x
Book Value ₹ 31.9
PEG Ratio -46.5x
ROE 0.8%
P/B 0.8x
Shareholding Pattern

Institutions
Elara India Opportunities Fund Limited
9.5 %
Marshal Global Capital Fund Ltd
9.5 %
Amol Anand Mantri
1.73 %
Iepf
0.75 %
Promoters
Balaxi Overseas Private Limited
70.0 %
Ashish Maheshwari
1.81 %
Minoshi Maheshwari
1.06 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
Investors (20)
Followers (1)